Cholecystokinin octapeptide (CCK-8) is present within midbrain dopamine (DA)-containing neurons and appears to act as a cotransmitter. The importance of these DA neurons in current hypotheses of the etiology and treatment of several neurological and psychiatric disorders requires that their physiology and their pharmacological responsiveness be well understood. In recent years, much has been learned about the receptor subtypes which mediate the effects of CCK-8 on DA neurons, but much remains to be learned about the scope and sites of CCK-8 actions In the midbrain. The studies proposed in this application are intended to evaluate possible sites of action for modulatory effects of CCK-8 on the electrophysiological activity of DA neurons in anesthetized rats. The serotonergic input to the midbrain from the dorsal raphe nucleus Influences the electrophysiological activity of DA neurons. In the first set of proposed experiments, Interactions of CCK-8 with the effects of dorsal raphe nucleus stimulation (and with serotonin itself on nigrostriatal and mesoaccumbal DA neuronal activity will be evaluated. Non-DA interneurons in the substantia nigra pars reticulata (SNr). Influence the activity of nigral DA neurons and may be accessible to locally released CCK-8. The SNr is also the source of non-DA nigrothalamic and nigrotectal neurons which are important links in the extrapyramidal motor system. Thus, the effects of CCK-8 on the activity of SNr interneurons and antidromically identified nigrothalamic and nigrotectal neurons will be determined. The neurotoxin 6-OHDA causes the degeneration of DA neurons and is used to produce an animal model of Parkinson's disease. The pharmacological responsiveness of the remaining DA neurons has been shown to be greatly altered. Because of the intimate relationship between CCK-8 and DA, it is possible that the responsiveness of remaining DA neurons to CCK-8 is changed in the 6-OHDA-lesioned rat. Such a change In responsiveness would have important implications for the regulation of DA neuronal function in the lesioned rat and, by inference, certain disease states. In the last set of experiments, the effects of CCK-8 on remaining DA neurons in the 6-OHDA-lesioned rat will be tested. The effects of the lesions on DA levels and CCK-8 levels in the midbrain DA cell body region and in DA cell projection sites will also be determined.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
2R01MH042136-04A1
Application #
3381209
Study Section
Neuropharmacology and Neurochemistry Review Committee (NPNC)
Project Start
1988-09-01
Project End
1995-08-31
Budget Start
1992-09-15
Budget End
1993-08-31
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
Schools of Medicine
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Hamilton, M E; Weddige, F K; Freeman, A S (2001) Effects of forebrain microinjection of cholecystokinin on dopamine cell firing rate. Peptides 22:1063-9
Hamilton, M E; Redondo, J L; Freeman, A S (2000) Overflow of dopamine and cholecystokinin in rat nucleus accumbens in response to acute drug administration. Synapse 38:238-42
Parikh, H N; Chiodo, L A; Koss, J et al. (1995) Cholecystokinin mobilizes intracellular Ca2+ in hybrid N18TG2 X mesencephalon (MES-23.5) cells. Synapse 21:278-80
Pitts, D K; Wang, L; Kelland, M D et al. (1995) Repeated stimulation of dopamine D2-like receptors: reduced responsiveness of nigrostriatal and mesoaccumbens dopamine neurons to quinpirole. J Pharmacol Exp Ther 275:412-21
Rouillard, C; Freeman, A S (1995) Effects of electrical stimulation of the central nucleus of the amygdala on the in vivo electrophysiological activity of rat nigral dopaminergic neurons. Synapse 21:348-56
Hamilton, M E; Freeman, A S (1995) Effects of administration of cholecystokinin into the VTA on DA overflow in nucleus accumbens and amygdala of freely moving rats. Brain Res 688:134-42
Kelland, M D; Freeman, A S; Rubin, J et al. (1993) Ascending afferent regulation of rat midbrain dopamine neurons. Brain Res Bull 31:539-46
Zhang, J; Chiodo, L A; Freeman, A S (1993) Further characterization of the effects of BMY 14802 on dopamine neuronal activity. Synapse 15:276-84
Zhang, J; Chiodo, L A; Wettstein, J G et al. (1992) Acute effects of sigma ligands on the electrophysiological activity of rat nigrostriatal and mesoaccumbal dopaminergic neurons. Synapse 11:267-78
Zhang, J; Chiodo, L A; Freeman, A S (1991) Effects of the CCK-A receptor antagonist CR 1409 on the activity of rat midbrain dopamine neurons. Peptides 12:339-43

Showing the most recent 10 out of 22 publications